Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ST13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CFAP97 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPOLA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLAIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPS15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC30A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSKIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPYSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PANK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2Q2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM120A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCOC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VWC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLASP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on